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The adult pancreas lacks stem cells, and consequently, differentiation of pancreatic endocrine cells has been
restricted to embryonic development or experimental manipulation. In this issue of Cell Stem Cell, Sancho
et al. (2014) show that pancreas-specific loss of the ubiquitin ligase Fbxw7 stabilizes an endocrine-specific
transcription factor, Ngn3, thus inducing in vivo b cell neogenesis.The pancreas is composed of exocrine
(acinar and ductal) cells and endocrine
(a, b, d, pp, and ε) cells, which function
by secreting enzymes and hormones
(Edlund, 2002). Pancreatic b cells secrete
insulin, and their destruction in patients
with type I diabetes mellitus renders the
patients hyperglycemic (Atkinson et al.,
2011). While treatment options include in-
sulin injections or potential cell replace-
ment therapies with in-vitro-generated b
cells (Pagliuca and Melton, 2013), b cellFigure 1. Control of Adult Pancreatic Cell Reprogramming by
SCFFbxw7-Mediated Ubiquitination
In the control pancreatic duct, SCFFbxw7 polyubiquitylates and targets Ngn3
for proteasome degradation. In the Fbxw7-deleted pancreatic duct, Ngn3 is
stabilized and activates transcription of targets that function in b cell differen-
tiation. SCFFbxw7 also controls the ubiquitination of proteins involved in cell
growth, cell cycle, and cell fate. As indicated by question marks, whether
Fbxw7 controls adult pancreatic cell reprogramming through coordinated
regulation of multiple substrates and cellular processes remains to be deter-
mined.neogenesis has only been
accomplished in vivo under
limited circumstances using
experimental manipulation,
such as pancreatic duct liga-
tion (Inada et al., 2008) or
adenoviral overexpression of
transcription factors (Zhou
et al., 2008). In this issue of
Cell Stem Cell, Sancho et al.
report a new mechanism for
generating b cells in vivo: ge-
netic deletion of the ubiquitin
ligase Fbxw7, which normally
destabilizes the transcription
factor Ngn3 and stimulates
the direct conversion of pan-
creatic ductal cells into endo-
crine b cells (Figure 1).
Ubiquitination regulates a
diverse range of cellular pro-
cesses to maintain cellular
homeostasis. The process in-
cludes activation by an E1
enzyme, transfer of ubiquitin
to an E2 conjugating enzyme,
and ubiquitin ligation onto a
substrate protein via an E3
ligase (Pickart, 2001). Cullin
proteins constitute the largest
family of E3 ligases and func-tion by binding a small RING protein,
either ROC1 or ROC2 (also known as
Rbx), which interact with the E2 enzyme
to comprise the catalytic moiety. A
remarkable feature of cullin proteins, of
which there are nine types in human cells,
is that individual cullins selectively interact
with different motifs, such as the F-box,
SOCS box, BTB domain, and WD40
repeat, that are present in many pro-
teins, which allows cullins to recruit spe-
cific substrates for ubiquitination by theCell Stem Cell 1RING-E2 catalytic moiety. One such fac-
tor, Fbxw7, is an F-box protein that
recruits substrates to CUL1. This E3
complex, referred to as SCF/CRL1Fbxw7,
mediates proteasomal degradation of
proteins involved in cell growth (c-Myc),
cell cycle regulation (Cyclin E), and cell
fate and differentiation (Notch) (Welcker
and Clurman, 2008).
Prompted by the role of Fbxw7 in
cell fate determination, Sancho and col-
leagues generated conditional knockout5, August 7,of Fbxw7 in embryonic pan-
creatic progenitor cells using
a Cre recombinase under
the control of the Pdx1 pro-
moter, which is active during
pancreas development and
in mature b cells. Surprisingly,
they discovered scattered
duct cells showing features
of functional mature b cells
both morphologically and
immunologically. Although
some cells in Fbxw7-deleted
ducts also expressed glu-
cagon, a marker of a cells,
the majority of the endocrine
cells were insulin positive.
Since embryonic progenitors
in the pancreas can differen-
tiate into all pancreatic line-
ages, Sancho and colleagues
next deleted Fbxw7 in the
adult pancreas using a ubiq-
uitously expressed, tamox-
ifen-inducible Cre recombi-
nase and found that Fbxw7
deletion in the adult pancre-
atic ductal cells, but not in
acinar cells, induced the con-
version into functional b cells.
This finding is particularly2014 ª2014 Elsevier Inc. 111
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Previewsinteresting since the adult pancreas lacks
progenitor cells (Dor et al., 2004).
To investigate which SCFFbxw7 sub-
strates may play a role during b cell emer-
gence in the Fbxw7-deleted pancreas, the
authors analyzed a panel of four transcrip-
tion factors known to be involved in em-
bryonic b cell development and found
that both the mRNA and protein levels of
Ngn3, but not those of the other three,
were strongly increased in Fbxw7-deleted
pancreas. They then demonstrated that
knockdown of Fbxw7 reduced Ngn3
ubiquitination and increased Ngn3 protein
half-life. Fbxw7 binds to Ngn3 and this
binding, like the interactions between
many other F-box proteins and their sub-
strates, requires the GSK3b-mediated
phosphorylation of Ngn3 on two adjacent
serine residues, a characteristic feature
of phosphodegron motifs. Conditional
transgenic expression of a phosphode-
gron mutant Ngn3, in the presence of
endogenously expressed Fbxw7, quickly
(within 24 hr) resulted in the emergence
of insulin-positive b cells in the pancreas.
Together with the results from the
pancreas-conditional deletion of Fbxw7,
these findings suggest that the b cells
arise through direct conversion of ductal
cells rather than an intermediate progeni-
tor cell that divides prior to differentiation
(Sancho et al., 2014).112 Cell Stem Cell 15, August 7, 2014 ª2014Aside from identifying Fbxw7 as a regu-
lator of cell fate decision in both embry-
onic and adult pancreas and showing an
example of direct ductal-to-b cell con-
version, the study offers new evidence
consistent with the lack of stem/progeni-
tor cells in the adult pancreas. It also high-
lights the latent plasticity of mature adult
cells, which are generally viewed as termi-
nally differentiated. However, there are
two important issues that remain to be
determined. First, unlike most other E3
substrates whose mRNA levels remain
largely unchanged when the E3 function
is disrupted, the mRNA level of Ngn3 is
also increased in Fbxw7-deleted cells.
Although the authors propose a positive
feedback loop to explain this perplexing
phenomenon, both the direct evidence
supporting this loop and its significance
are yet to be demonstrated. Second,
Fbxw7 also degrades several additional
proteins that play a critical role in regu-
lating cell growth, proliferation, and fate
(Figure 1). Whether these proteins are
also regulated by Fbxw7 in the embryonic
and adult pancreas has not been exam-
ined. Does Fbxw7 control b cell neo-
genesis solely through Ngn3 or through
coordinated regulation of multiple sub-
strates? Ultimately, the in vivo induction
of functional b cells may be a viable treat-
ment option for patients with type 1 dia-Elsevier Inc.betes mellitus, and the current finding of
the SCF/CRL1Fbxw7-Ngn3 axis in control-
ling direct ductal-to-b cell conversion
offers a new target for this exploration.ACKNOWLEDGMENTS
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Although mesenchymal stem/stromal cells (MSCs) are an important component of the hematopoietic niche,
the markers that correlate with their physiological functions have not been defined. In this issue of Cell Stem
Cell, Zhou et al. (2014) identify the Leptin Receptor as a marker for prospective identification and in vivo fate
mapping of bone marrow MSCs.Mesenchymal stem/stromal cells (MSCs)
have been defined as nonhematopoietic,
plastic-adherent, colony-forming cellsthat are capable of in vitro trilineage
differentiation into fat, bone, and cartilage
(Pittenger et al., 1999). While MSCs canbe retrospectively identified based on
their ability to produce colony-forming
unit fibroblasts (CFU-Fs) in vitro, an
